Gene · 5598
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Down-regulation of SHP2 promotes neutrophil autophagy and inhibits neutrophil extracellular trap formation to alleviate asthma through the ERK5 pathway. | Cent Eur J Immunol | 2024 | 39720267 | PubTator, text mining | PubMed |
| The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies. | Front Oncol | 2024 | 39582535 | PubTator, text mining | PubMed |
Corrigendum to "Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5/CXCR4, Orai-1/STIM-1 signaling pathways" [Int. Immunopharmacol. 140 (2024) 112777]. | Int Immunopharmacol | 2024 | 39572317 | PubTator, text mining | PubMed |
| Low fluid shear stress promotes chondrocyte proliferation and extracellular matrix secretion by downregulating mir-143-3p and activating the ERK5/KLF4 signaling pathway. | Sci Rep | 2024 | 39532925 | PubTator, text mining | PubMed |
| Vaping/e-cigarette-induced pulmonary extracellular vesicles contribute to exacerbated cardiomyocyte impairment through the translocation of ERK5. | Life Sci | 2024 | 39481834 | PubTator, text mining | PubMed |
| Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman disease. | J Clin Exp Hematop | 2024 | 39462545 | PubTator, text mining | PubMed |
| Sports-Related Genomic Predictors Are Associated with Athlete Status in Chinese Sprint/Power Athletes. | Genes (Basel) | 2024 | 39457375 | PubTator, text mining | PubMed |
| Low shear stress protects chondrocytes from IL-1β-induced apoptosis by activating ERK5/KLF4 signaling and negatively regulating miR-143-3p. | J Orthop Surg Res | 2024 | 39402582 | PubTator, text mining | PubMed |
| Macrophage MAPK7/AhR/STAT3 Signaling Mediates Mitochondrial ROS Burst and Enterohepatic Inflammatory Responses Induced by Deoxynivalenol Relevant to Low-Dose Exposure in Children. | Environ Sci Technol | 2024 | 39376183 | PubTator, text mining | PubMed |
| NADPH oxidase 1/4 dual inhibitor setanaxib suppresses platelet activation and thrombus formation. | Life Sci | 2024 | 39293714 | PubTator, text mining | PubMed |
| The doublecortin-family kinase ZYG-8DCLK1 regulates microtubule dynamics and motor-driven forces to promote the stability of C. elegans acentrosomal spindles. | PLoS Genet | 2024 | 39226307 | PubTator, text mining | PubMed |
| Insight in the (Phospho)proteome of Vascular Smooth Muscle Cells Derived From Patients With Abdominal Aortic Aneurysm Reveals Novel Disease Mechanisms. | Arterioscler Thromb Vasc Biol | 2024 | 39206541 | PubTator, text mining | PubMed |
| ERK5 promotes autocrine expression to sustain mitogenic balance for cell fate specification in human pluripotent stem cells. | Stem Cell Reports | 2024 | 39151429 | PubTator, text mining | PubMed |
| ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2. | Biochim Biophys Acta Mol Cell Res | 2024 | 39128596 | PubTator, text mining | PubMed |
| Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5/CXCR4, Orai-1/STIM-1 signaling pathways. | Int Immunopharmacol | 2024 | 39088923 | PubTator, text mining | PubMed |
| Statins enhance extracellular release of hepatitis C virus particles through ERK5 activation. | Microbiol Immunol | 2024 | 39073705 | PubTator, text mining | PubMed |
| Mechanism and application of feedback loops formed by mechanotransduction and histone modifications. | Genes Dis | 2024 | 39071110 | PubTator, text mining | PubMed |
| Proteogenomic insights into the biology and treatment of pan-melanoma. | Cell Discov | 2024 | 39039072 | PubTator, text mining | PubMed |
| The ERK5 pathway in BRAFV600E melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenib. | FEBS Lett | 2024 | 38977937 | PubTator, text mining | PubMed |
| Editorial for the Special Issue "MAPK in Health and Disease". | Int J Mol Sci | 2024 | 38928367 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5598/papers?page=7